Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20187251 20158064 0 65 Palliative (P) 2018-06-13 2018-06-13 Bevacizumab + Olaparib 02 N VINORELBINE 101844547
20187474 20158065 1.75 77 Palliative (P) 2019-05-22 2019-07-15 MIC 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE 100259446
20188987 20158068 1.79 null Adjuvant (A) null 2021-01-18 CAV N N CISPLATIN + FLUOROURACIL + MITOMYCIN 101684297
20189120 20158069 1.48 72.8 Adjuvant (A) 2017-01-17 2017-01-26 CAM-PLEX Trial 02 N INTERAACT TRIAL 100307706
20189383 20158070 1.65 78 Palliative (P) 2022-01-15 2022-01-19 BORTEZOMIB + THALIDOMIDE 02 N TCH 100701518
20189860 20158071 0 101.3 null 2018-05-11 2018-06-01 CAPECITABINE + IRINOTECAN + Panitumumab 02 null FLUOROURACIL + RT 100219824
20189888 20158072 1.64 115.6 Curative (C) 2017-12-19 2017-12-25 Capecitabine + Streptozocin 02 N ECF 100851622
20189892 20158073 1.91 94 Curative (C) null 2018-06-25 OSIMERTINIB 02 N CETUXIMAB + FLUOROURACIL 100827881
20190292 20158074 1.75 91.5 null 2020-04-08 2020-04-08 Azacitidine 02 N ACTICCA-1 TRIAL 101266166
20190704 20158075 1.6 72.8 Palliative (P) 2018-05-19 2019-02-21 Bortezomib + Daratumumab 02 N ECF 101768149
20190786 20158076 1.82 94 null 2019-01-09 2019-01-10 CISPLATIN + FLUOROURACIL + Trastuzumab 02 null CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 101626160
20190951 20158077 1.98 61 null 2017-10-16 2018-03-06 CAPECITABINE + MITOMYCIN + RT 02 N PERTUZUMAB + TRASTUZUMAB 101577790
20191296 20158078 0 117.1 03 2019-07-28 2019-07-28 Temozolomide + RT 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE 101505778
20191467 20158079 1.56 60.5 03 2019-01-23 2019-02-03 Trastuzumab + VINORELBINE 02 N BRENTUXIMAB 100543125
20191722 20158080 1.75 69 Palliative (P) 2018-09-27 2019-07-12 Pemetrexed 02 N CETUXIMAB + IRINOTECAN 100789396
20191880 20158081 1.51 63.8 Palliative (P) 2017-07-19 2017-08-29 FOCUS4 TRIAL 02 null CARBOPLATIN + TEYSUNO 100512570
20192236 20158082 null null Palliative (P) 2016-05-29 2016-05-29 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N OXALIPLATIN + MDG + PANITUMUMAB 101713994
20192517 20158083 1.53 60 Adjuvant (A) 2019-05-12 2019-06-14 FLUOROURACIL + RT 02 null BINIMETINIB + ENCORAFENIB 100811264
20192598 20158084 1.82 72.4 Palliative (P) 2019-11-14 2019-11-27 ECarboX 02 N IPILIMUMAB 101596904
20192633 20158085 1.72 53.2 null 2018-04-16 2018-05-27 CISPLATIN + FLUOROURACIL + Trastuzumab N N CABAZITAXEL 100468754
20192799 20158087 1.52 80.2 null 2017-04-29 2017-07-26 CISPLATIN + FLUOROURACIL + RT 02 null CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 101216402
20192828 20158088 1.71 80.2 Curative (C) 2016-07-03 2016-07-05 Bortezomib + CYCLOPHOSPHAMIDE 02 N CISPLATIN + RT 100317739
20193514 20158090 1.81 67.7 null 2019-03-29 2019-04-08 Carboplatin + Cetuximab (>Cycle 2) 02 null EOF 100967649
20193552 20158091 1.6 7.7 Palliative (P) 2019-09-27 2019-10-22 Cetuximab +Cisplatin + FU (Cycle 1) 02 N CISPLATIN + VINORELBINE 100636346
20193638 20158092 1.85 73.9 Palliative (P) 2019-08-21 2019-11-21 CAP + RT 02 N THALIDOMIDE 101825471
20193764 20158093 1.71 105 Neo-adjuvant (N) 2018-07-24 2018-08-08 Rituximab 02 N CISPLATIN + PEMETREXED 100878145
20193788 20158094 1.53 65.3 Palliative (P) 2018-01-22 2019-01-09 Chlorambucil 02 null GEMCITABINE + OXALIPLATIN 100021253
20193816 20158095 1.57 73 Palliative (P) 2019-09-07 2019-11-01 Irinotecan + Raltitrexed N null CISPLATIN + CYTARABINE + ETOPOSIDE + RITUXIMAB 100567206
20194172 20158096 1.79 74.2 Palliative (P) 2017-12-10 2017-12-10 Hydroxycarbamide 02 N DOCETAXEL + PERTUZUMAB + TRASTUZUMAB 100352389
20194533 20158098 1.61 98.4 null 2017-08-21 2017-09-01 CHOP R - 21 days 02 null OXALIPLATIN + MDG + PANITUMUMAB 100062470
20194727 20158099 1.83 84.4 03 2017-04-29 2017-05-28 Melphalan IV High dose 02 null EOF 101849873
20194746 20158100 1.71 56 Curative (C) 2016-03-30 2016-08-12 Capecitabine+Cisplatin+Streptozocin null N BORTEZOMIB + RITUXIMAB 101348927
20194882 20158101 1.65 104.3 null 2019-10-02 2019-12-31 ECarboX 02 N CAPECITABINE + LOMUSTINE 100175880
20195081 20158103 1.81 68.8 Curative (C) 2018-12-09 2019-02-28 BALLAD Trial 02 N GEMCITABINE + OXALIPLATIN 100873840
20195087 20158104 1.65 null Curative (C) 2020-05-25 2020-05-25 null 02 null GEMCITABINE + PACLITAXEL 100076109
20195211 20158105 1.77 73.2 null 2018-12-22 2018-12-23 ARISTOTLE TRIAL 02 null COSMIC TRIAL 100134615
20195253 20158106 1.57 null Adjuvant (A) 2014-12-19 2015-02-26 Bevacizumab + Irinotecan + MdG 01 N BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN 100199770
20195460 20158107 1.66 94.55 Neo-adjuvant (N) 2019-04-13 2019-05-23 Letrozole + Palbociclib N null PHITT D2 CARBOPLATIN / ETOPOSIDE 101552716
20195643 20158108 1.81 182 null 2018-05-27 2018-05-27 CETUXIMAB + MDG 02 null CARBOPLATIN + VINORELBINE 101731291
20195682 20158109 1.52 64.1 null 2018-04-23 2018-05-15 Bevacizumab + CAPECITABINE + OXALIPLATIN 2 null CAPECITABINE + CISPLATIN + MITOMYCIN 100723794
20197298 20158111 1.3 61.8 Neo-adjuvant (N) 2019-09-13 2019-09-13 CTD N N AML18 TRIAL 101227674
20197652 20158112 1.75 67.4 03 2018-06-11 2018-06-16 Bevacizumab + Irinotecan + MdG 02 N CISPLATIN + DOXORUBICIN 101151692
20197694 20158113 1.82 69.3 Palliative (P) 2019-11-04 2020-04-18 CETUXIMAB + IRINOTECAN 02 N CYCLOPHOSPHAMIDE + THALIDOMIDE 100150951
20197771 20158114 1.8 84.2 Palliative (P) 2019-05-21 2019-05-21 null 02 N FLUDARABINE 101740973
20198018 20158115 1.8 76.9 null 2022-04-03 2022-04-07 Bortezomib + MELPHALAN 02 null GEMCITABINE + TEYSUNO 100764418
20198106 20158116 1.55 0 null 2018-11-01 2018-12-05 Epirubicin 01 null ARISTOTLE TRIAL 101499597
20198126 20158117 1.65 85.1 Palliative (P) 2020-11-20 2020-12-01 ECF 02 N ICE 100341536
20198192 20158118 0 69.9 Palliative (P) 2019-09-28 2019-09-29 Docetaxel+Gemcitabine (no prior RT) N null OSIMERTINIB 100980667
20198502 20158119 1 null null 2018-04-19 2018-04-20 Eribulin 02 null NEO-AEGIS TRIAL 100826449
20198916 20158120 1.65 88.2 Palliative (P) 2019-02-23 2021-08-09 Bevacizumab + Irinotecan + MdG Y null ARISTOTLE TRIAL 100498854